Molecular Biomarker Testing in Localized Prostate Cancer: The Critical Role of Pathologists

Arch Pathol Lab Med. 2021 Mar 1;145(3):264-265. doi: 10.5858/arpa.2020-0641-ED.

Authors

Ezra Baraban¹, George Netto², Christina B Ventura³, Ming Zhou⁴

Affiliations

¹ From the Department of Pathology, Hospital of the University of Pennsylvania, Philadelphia (Baraban).
² The Department of Pathology, The University of Alabama at Birmingham, Birmingham (Netto).
³ The Pathology and Laboratory Quality Center for Evidence-Based Guidelines, College of American Pathologists, Northfield, Illinois (Ventura).
⁴ The Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, Massachusetts (Zhou).

PMID: 33351911
DOI: 10.5858/arpa.2020-0641-ED

No abstract available

Publication types

Editorial

MeSH terms

American Medical Association
Biomarkers / analysis*
Humans
Male
Medical Oncology
Pathologists
Practice Guidelines as Topic
Prostate / metabolism
Prostate / pathology
Prostatic Neoplasms / metabolism
Prostatic Neoplasms / pathology*
United States

Substances

Biomarkers